Healthcare Triangle, Inc. HCTI

Healthcare Triangle (NASDAQ:HCTI) signed a non-binding letter of intent to acquire Roboticom’s specified customer contracts, IP, trademarks and other assets for up to $30 million in cash and equity paid over time; terms and payment mix not disclosed. Roboticom generated about $14.1 million in revenue and $6.9 million in gross margin for fiscal 2025 and was EBITDA-positive, per unaudited information. Roboticom management projects roughly $153.5 million in revenue and $64 million in adjusted operating contribution by fiscal 2029/30, but these figures are unaudited and uncertain. Completion would diversify HCTI from healthcare cloud, data and AI into industrial robotics and precision automation. Roboticom markets SandRob, ORTIS and ScultoRob across aerospace, automotive, orthotics and more. The LOI is preliminary; due diligence will verify asset title, and definitive terms on cash vs. equity, financing and payment schedule remain to be seen. Non-binding LOI for a up-to-$30 million acquisition signals a major strategic diversification that could shift core operations, but results are contingent on due diligence and definitive terms.

Healthcare Triangle, Inc. signed a non-binding LOI to pursue acquisition of Roboticom's intellectual property, trademarks and business assets for up to $30 million in cash and equity. Roboticom, Italy-based, markets SandRob, ORTIS and ScultoRob robotic automation systems serving aerospace, marine, orthotics, automotive and other industries; FY2025 revenue was about $14.1 million with $6.9 million gross margin and was EBITDA-positive. Roboticom management's five-year plan targets roughly $153.5 million revenue and $64 million in adjusted operating contribution by FY2029/30, but projections are unaudited and unverified by HCTI and subject to substantial uncertainty. The deal would transfer 100% of customer contracts and assets with up to $30 million consideration paid over time, contingent on due diligence, financing and definitive agreements; LOI non-binding. CFO David Ayanoglou calls the move a potential opportunity to combine HCTI’s AI/cloud capabilities with Roboticom's platform to expand into industrial robotics. Represents a major strategic expansion into industrial robotics with sizable revenue potential, contingent on due diligence and a definitive agreement.

Healthcare Triangle (Nasdaq: HCTI) joins Kanzun-ARCB Growth Fund to build Malaysia-to-US corridor for AI and healthcare companies. Partnership enables HCTI to pursue major strategic expansion in cross-border AI and healthcare markets.

Healthcare Triangle (Nasdaq: HCTI) joins Kanzun-ARCB Growth Fund to build a Malaysia-to-US corridor for AI and healthcare companies. Partnership enables HCTI to pursue international expansion in AI and healthcare via new Malaysia-US corridor.

Healthcare Triangle, Inc. (HCTI) spins off Teyame to benefit shareholders. Spin-off of Teyame is a major strategic move that could significantly alter HCTI's trajectory and investor sentiment.

Healthcare Triangle, Inc. will distribute its minority interest in Teyame AI Holdings Inc. common shares as stock dividends to HCTI shareholders in connection with a planned direct listing. Distribution of minority shares linked to direct listing may moderately affect HCTI shareholder value and market positioning.

Healthcare Triangle, Inc. (HCTI) shows positive results from recent changes. Operational changes are producing measurable benefits for HCTI performance.

Healthcare Triangle reports 322% gross profit increase and 158% revenue growth for Q2 2026. Exceptional profit and revenue growth signals major positive shift in financial trajectory and market positioning.

Healthcare Triangle Inc. (HCTI) posted 322% gross profit growth and 158% revenue growth for Q2 2026. Large revenue and profit gains signal stronger operations and investor appeal.

HCTI's Teyame generated a full year of client revenue in six months with a €2 million target. Early revenue milestone signals accelerated growth that can shift HCTI's financial trajectory.

HCTI's Teyame generated a full year's client revenue in six months toward a €2 million target. Teyame's revenue acceleration signals stronger HCTI growth and investor appeal.

Healthcare Triangle signs non-binding LOI to acquire 51% of CosmoInnovations, entering high-growth proprietary MedTech and consumer-health markets. Non-binding LOI for majority stake in CosmoInnovations opens high-growth MedTech and consumer-health markets for HCTI.

Healthcare Triangle (HCTI) signed a non-binding LOI to acquire 51% of CosmoInnovations, entering high-growth proprietary MedTech and consumer-health markets. Non-binding LOI for 51% acquisition of CosmoInnovations enables HCTI entry into MedTech and consumer-health markets with significant growth potential.

Healthcare Triangle, Inc. (HCTI) issues new shares, providing capital that supports future growth and operations. Share issuance supplies fresh capital that can fund expansion without fundamentally shifting company trajectory.

Healthcare Triangle, Inc. issued shares tied to prior M&A deals, meeting Nasdaq's $5 million market value listing standard. Share issuances secure Nasdaq listing compliance and may stabilize trading access.

HCTI launches Purpose Health to monetize AI demand and accelerate shareholder returns. New Purpose Health unit targets AI monetization as a major strategic move likely to alter HCTI trajectory and sentiment.

Healthcare Triangle, Inc. launches Purpose Health to monetize AI demand and accelerate shareholder returns. Launch of Purpose Health targets AI monetization with potential to reshape HCTI growth and investor outlook.

Healthcare Triangle, Inc. closed a private placement offering of original issue discount senior convertible promissory notes, generating approximately $3.6 million in gross proceeds. The $3.6 million capital infusion improves HCTI liquidity and may support near-term operations without transforming core trajectory.

Healthcare Triangle closed a private placement of original issue discount senior convertible promissory notes, raising $3.6 million in gross proceeds. The capital injection improves liquidity yet carries dilution risk from convertible notes without shifting core operations.

Healthcare Triangle, Inc. (HCTI) reported a 627% increase in gross profit and 166% increase in revenue for Q1 2026. Explosive 627% gross profit and 166% revenue growth fundamentally transform HCTI's financial position and market prospects.

Healthcare Triangle Inc. (HCTI) posted a 627% gross profit increase and 166% revenue growth for Q1 2026. Explosive revenue and gross profit growth signals transformative financial performance that can fundamentally elevate market position and investor outlook.

Healthcare Triangle, Inc. (HCTI) reports rapid revenue growth, highlighting strong financial momentum and expanding operations in healthcare IT services. Rapid revenue growth signals major financial improvement, poised to significantly boost HCTI's market performance and investor confidence.

Healthcare Triangle, Inc. (HCTI) launched ZoraNex, an AI-driven digital self-care therapy platform targeting the $450 billion global mental health market. Launching an AI-driven platform into the $450B mental health market is a major strategic move with high potential to enhance HCTI's growth and market position.

Healthcare Triangle, Inc. launches ZoraNex, an AI-driven digital self-care therapy platform targeting the $450B global mental health market. ZoraNex launch represents major product introduction in large mental health sector with potential to shift company trajectory and investor interest.

Healthcare Triangle, Inc. (HCTI) released earnings demonstrating great improvement. Earnings showing great improvement will significantly enhance HCTI's financial position and investor sentiment.

Healthcare Triangle, Inc. (HCTI) acquires new clients in Africa, entering the $412 billion market. Acquiring clients in Africa's $412 billion market marks a major strategic expansion with high potential to boost HCTI's revenue and market presence.

Healthcare Triangle, Inc. (HCTI) acquires new clients in Africa and enters the $412 billion market. Entry into African market with new clients marks major expansion that can significantly boost HCTI revenue and trajectory.

Healthcare Triangle, Inc. (HCTI) launched an Agentic AI Agent for healthcare services. Launching an Agentic AI agent marks a major strategic product innovation in the high-growth AI healthcare sector.

Healthcare Triangle, Inc. (HCTI) launched an Agentic AI Agent to enhance healthcare services with advanced automation and intelligence. Launching an Agentic AI Agent marks a significant strategic product innovation in the high-growth AI healthcare sector, likely elevating HCTI's competitive edge and market performance.

HCTI 4Q25 earnings preview spotlights upcoming M&A activity, capital reload, and share buybacks to drive growth. M&A, capital reload, and buybacks signal major strategic initiatives to boost growth and shareholder value.